Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Goos (Leuven, Belgium), L. De Sadeleer (Leuven, Belgium), E. Verbeken (Leuven, Belgium), G. Verleden (Leuven, Belgium), J. Verschakelen (Leuven, Belgium), J. Yserbyt (Leuven, Belgium), S. Verleden (Leuven, Belgium), W. Wuyts (Leuven, Belgium). A family history of ILD is a significant risk factor for worse transplant-free survival in IPF patients. 448

Member's Comments

No comment yet.

Related content which might interest you: Gender-dependent predictors for survival in patients with COPD Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients Source: ERJ Open Res, 5 (2) 00021-2019; 10.1183/23120541.00021-2019 Year: 2019 Survival and predictive factors of mortality in patients with bronchiectasis Source: Eur Respir J 2006; 28: Suppl. 50, 60s Year: 2006 The survival of patients afflicted with COPD and influencing factors Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 Is age a predictor in prognosis of patients with idiopathic pulmonary fibrosis? Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 The effect of comorbidities on long-term survival in COPD Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Pilot: identification of rehospitalization risk factors for patients with COPD Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital Year: 2005 Risk factor biomarker differences in rehospitalization for patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 838s Year: 2006 Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome Source: Eur Respir J 2011; 37: 356 Year: 2011 Mortality in bronchiectasis: a long-term study assessing the factors influencing survival Source: Eur Respir J 2009; 34: 843-849 Year: 2009 Pre-COVID-19 lung function and other risk factors for severe COVID-19 in first responders Source: ERJ Open Res, 7 (1) 00610-2020; 10.1183/23120541.00610-2020 Year: 2021 Factors associated with poor prognostic outcome in acute exacerbation of COPD Source: Annual Congress 2009 - Treatment of airways disease Year: 2009 Pulmoanry hypertension is a negative prognostic factot of long term survival in patients with idiopathic pulmonary fibrosis after lung transplantation Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 The natural history of COPD without co-morbidities: predictors of long-term mortality Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD Year: 2009 Factors affecting survival of bronchiectasis patients Source: Annual Congress 2008 - Respiratory structure and function Year: 2008 Predictors of mortality in a well-characterised group of patients with COPD Source: Annual Congress 2012 - COPD: epidemiology and varia Year: 2012 MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension. Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 Candidacolonization in lung cancer patients and its role as a prognostic factor for infection occurrence during hospitalization Source: Eur Respir J 2003; 22: Suppl. 45, 433s Year: 2003 Do worse scores on patient-reported outcomes predict the progression of interstitial lung disease (ILD)? Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Gender is an independent risk factor on lung cancer survival but not non-smoking Source: Annual Congress 2010 - Epidemiology of lung cancer Year: 2010